Press Releases June 4, 2026 08:30 AM

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Intelligent Bio Solutions to attend Planet MicroCap Conference June 16-18, showcasing rapid fingerprint-based drug testing technology

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
INBS

Intelligent Bio Solutions Inc., a Nasdaq-listed medical technology company specializing in rapid, non-invasive testing solutions, announced participation in the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The management team will present and hold one-on-one investor meetings, highlighting their Intelligent Fingerprinting Drug Screening System designed for hygienic, quick drug detection in various industries.

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
INBS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The company will present at the Planet MicroCap Conference in Las Vegas on June 17, 2026.
  • Showcases Intelligent Fingerprinting Drug Screening System with results under ten minutes.
  • Targets safety-critical industries requiring rapid, non-invasive drug testing, including construction, manufacturing, transport, mining, and drug treatment sectors.

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Planet MicroCap Conference on June 16-18, 2026, in Las Vegas, NV.

Conference Details
Date: June 16-18, 2026
Location: Bellagio Hotel & Casino, Las Vegas
Presentation Date and Time: Wednesday, June 17, 2026, at 8:00 – 8:30 AM PDT
Presentation Location: Track 7 – Donatello 3
Registration: Interested investors can register to attend here
Webcast: Viewable here
Booth: 413

The Company will be participating in one-on-one investor meetings throughout the event. For more information about the conference, or to schedule a meeting with the INBS management team, please contact your Planet MicroCap representative or email KCSA Strategic Communications at [email protected].

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners. 

For more information, visit: https://ibs.inc/ 

Company Contact 
Intelligent Bio Solutions Inc.  
[email protected] 

Investor & Media Contact  
Valter Pinto, Managing Director  
KCSA Strategic Communications  
PH: (212) 896-1254  
[email protected] 


Risks

  • Market adoption of new fingerprint-based drug testing technology may be slow or face regulatory hurdles.
  • Dependence on expanding customer base outside the U.S. poses geographic market risks.
  • Competition from existing drug testing methods and companies could impact growth potential.

More from Press Releases

GEnx-1B Engines Surpass 50 Million Flight Hours Jul 19, 2026 XA Investments President Kimbery Flynn Speaks to Shareholders About XFLT Proxy Vote Jul 19, 2026 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population Jul 18, 2026 UFC Names Meridian Holdings Official Sponsor of Fight Night Belgrade Jul 18, 2026 What Every XFLT Shareholder Needs to Know for XFLT's Proxy Contest Jul 18, 2026